Efficacy of tocilizumab in treatment of COVID-19 pneumonia: A case–control study from a tertiary care hospital

Efficacy of tocilizumab in treatment of COVID-19 pneumonia: A case–control study from a tertiary care hospital

Background and Objective: Coronavirus disease 2019 (COVID-19) is a viral infectious disease caused by the severe acute respiratory syndrome virus, which has affected billions of people across the globe. The pathogenesis of respiratory inflammation involves elevated concentration of interleukin-6; he...

Full description

Bibliographic Details
Main Authors: Minal Shastri, Darshankumar Manubhai Raval, Ummayhany Fakhruddin Bharmal, Vaishnavi M Rathod, Bhavi Desai, Priyansh V Shah, Mohak Jain
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Lung India
Subjects:
adjuvant tocilizumab
covid-19 pneumonia
inflammatory score
moderate to severe disease
retrospective case–control study
sofa score
Online Access:http://www.lungindia.com/article.asp?issn=0970-2113;year=2022;volume=39;issue=6;spage=510;epage=516;aulast=Shastri

Internet

http://www.lungindia.com/article.asp?issn=0970-2113;year=2022;volume=39;issue=6;spage=510;epage=516;aulast=Shastri

Similar Items